No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Why We Think Nutriband Inc.'s (NASDAQ:NTRB) CEO Compensation Is Not Excessive At All
Shareholders in Nutriband (NASDAQ:NTRB) Are in the Red If They Invested Five Years Ago
Express News | Nutriband Inc: Targeting to File for FDA Approval for Aversa™ Fentanyl in First Half of 2025
10-Q: Q3 2025 Earnings Report
Nutriband Q3 EPS $(0.12) Up From $(0.22) YoY, Sales $645.80K Up From $427.84K YoY
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025